Natixis grew its position in Xylem Inc (NYSE:XYL) by 135.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 116,889 shares of the industrial products company’s stock after buying an additional 67,213 shares during the period. Natixis owned approximately 0.07% of Xylem worth $7,876,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of XYL. Wells Fargo & Company MN raised its holdings in Xylem by 1.0% in the first quarter. Wells Fargo & Company MN now owns 212,211 shares of the industrial products company’s stock worth $16,324,000 after buying an additional 1,999 shares during the last quarter. Mackay Shields LLC purchased a new position in Xylem in the first quarter worth about $2,655,000. Robeco Institutional Asset Management B.V. raised its holdings in Xylem by 688.9% in the first quarter. Robeco Institutional Asset Management B.V. now owns 66,641 shares of the industrial products company’s stock worth $5,126,000 after buying an additional 58,194 shares during the last quarter. Schwab Charles Investment Management Inc. raised its holdings in Xylem by 3.7% in the first quarter. Schwab Charles Investment Management Inc. now owns 892,488 shares of the industrial products company’s stock worth $68,651,000 after buying an additional 31,980 shares during the last quarter. Finally, Aperio Group LLC raised its holdings in Xylem by 2.9% in the first quarter. Aperio Group LLC now owns 203,407 shares of the industrial products company’s stock worth $15,646,000 after buying an additional 5,752 shares during the last quarter. 85.83% of the stock is owned by institutional investors and hedge funds.

In other Xylem news, Director Curtis J. Crawford sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 7th. The shares were sold at an average price of $76.26, for a total transaction of $571,950.00. Following the completion of the sale, the director now directly owns 40,421 shares of the company’s stock, valued at $3,082,505.46. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Paul A. Stellato sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $78.63, for a total transaction of $235,890.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 30,623 shares of company stock valued at $2,320,592. 0.81% of the stock is owned by corporate insiders.

Several brokerages have issued reports on XYL. Raymond James started coverage on shares of Xylem in a report on Wednesday, September 5th. They issued an “outperform” rating and a $90.00 target price for the company. BMO Capital Markets boosted their price objective on shares of Xylem from $83.00 to $84.00 and gave the company an “outperform” rating in a report on Wednesday, August 1st. Robert W. Baird reissued a “hold” rating and set a $80.00 price objective on shares of Xylem in a report on Wednesday, August 1st. Stifel Nicolaus boosted their price objective on shares of Xylem from $75.00 to $80.00 and gave the company a “hold” rating in a report on Wednesday, August 1st. Finally, Zacks Investment Research cut shares of Xylem from a “hold” rating to a “sell” rating in a report on Monday, July 16th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $82.82.

XYL opened at $80.78 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.43 and a quick ratio of 1.02. Xylem Inc has a twelve month low of $62.19 and a twelve month high of $81.32. The company has a market cap of $14.37 billion, a PE ratio of 33.66, a P/E/G ratio of 1.53 and a beta of 1.26.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.02. Xylem had a net margin of 7.39% and a return on equity of 19.04%. The firm had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.28 billion. During the same period in the previous year, the company earned $0.59 earnings per share. The firm’s quarterly revenue was up 13.1% on a year-over-year basis. research analysts predict that Xylem Inc will post 2.91 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 20th. Shareholders of record on Thursday, August 30th will be issued a dividend of $0.21 per share. The ex-dividend date is Wednesday, August 29th. This represents a $0.84 dividend on an annualized basis and a yield of 1.04%. Xylem’s dividend payout ratio is currently 35.00%.

About Xylem

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

See Also: How to Invest in Marijuana Stocks

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.